Anzeige
Mehr »
Samstag, 25.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0X93X | ISIN: SE0002016352 | Ticker-Symbol: 24C
Frankfurt
24.10.25 | 08:01
2,990 Euro
+3,28 % +0,095
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
C-RAD AB Chart 1 Jahr
5-Tage-Chart
C-RAD AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,9703,20512:46
GlobeNewswire (Europe)
120 Leser
Artikel bewerten:
(0)

C-Rad AB: Interim Report Q3 2025

Positive earnings trend and continued growth in Services

Third quarter July-September 2025

  • Order intake increased 7 percent to MSEK 106.4 (99.6), (11 percent at constant currencies).
  • Revenue increased 12 percent to MSEK 112.2 (100.1), (16 percent at constant currencies).
  • EBIT amounted to MSEK 21.2 (17.3), corresponding to a margin of 19 (17) percent.
  • Earnings after tax amounted to MSEK 12.9 (15.3). Adjusted for unrealized currency effects profit after tax amounted to MSEK 16.1 (16.1).
  • Earnings per share amounted to SEK 0.38 (0.45). Adjusted for unrealized currency effects, earnings per share amounted to SEK 0.48 (0.48).

Interim period January-September

  • Order intake increased 6 percent to MSEK 337.8 (318.6), (9 percent at constant currencies).
  • Revenue decreased 3 percent to MSEK 336.1 (347.5), (unchanged at constant currencies).
  • EBIT amounted to MSEK 39.6 (49.6), corresponding to a margin of 12 (14) percent. Adjusted for unrealized currency effects of total MSEK -10.6 (0.6) referring to the translation of operating items, EBIT amounted to MSEK 50.2 (49.0) corresponding to a margin of 15 (14) percent.
  • Earnings after tax amounted to MSEK 8.8 (42.0). Adjusted for unrealized currency effects profit after tax amounted to MSEK 41.2 (37.7).
  • Earnings per share amounted to SEK 0.26 (1.24). Adjusted for unrealized currency effects, earnings per share amounted to SEK 1.22 (1.12).

Significant event after the end of the period
On 21 October 2025, it was disclosed that the board and CEO Cecilia de Leeuw had agreed that she would leave the CEO role. Furthermore, the board decided to appoint the company's CFO Linda Frölén acting CEO. Johan Danielsson, who successfully built the global service business, was appointed as deputy CEO. Board member Peter Simonsbacka was hired on a consulting basis two days a week to accelerate the level of activity. The board has immediately started recruiting a new CEO. The one-time cost for management changes 2025 is estimated at approximately 5 million SEK and will be recognized in the fourth quarter.

Updated invitation to investor presentation
Acting CEO Linda Frölén and deputy CEO Johan Danielsson will present the report in English as planned on October 23, at 11:00 a.m. CET.

Date: Thursday, October 23, 2025
Time: 11:00 CET

For information, please contact Linda Frölén, acting CEO.

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

This information is information that C-Rad is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-21 19:00 CEST.

© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.